Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.
COVID-19, FDA drug approvals and new approaches to treatment and quality of life stood out among this year’s top stories.
After being treated for thyroid cancer with a rare mutation, Susan is helping educate others.
Targeted therapy demonstrated high response rates for thyroid tumors with RET mutations or fusions.
Help spread the word about early detection, treatment, and ThyCa’s free support and education.
These cancers include those that are rare among adults under 40, such as breast, colon, pancreas, kidney, prostate and ovarian cancer.
These are the latest cancer treatments approved by the FDA.
Selpercatinib, the first drug in its class, shrank tumors in over two thirds of previously treated patients.
The author of a new survey study suggested that using such words may invalidate cancer patients’ experiences.
John Duggan has survived both stage III colon cancer and thyroid cancer before age 30.
New insights may help scientists develop better drugs to intervene in cancers, such as melanoma and thyroid cancer
New site-agnostic therapies highlight the importance of genetic testing.
Mark Ruffalo stars as a lawyer who takes on a chemical giant in this movie inspired by real events.
Those with bladder, larynx, prostate, womb, bowel and breast cancers have the highest rate of death related to cardiovascular disease.
Two studies suggest that bariatric surgery may prevent obesity-related cancers, including breast cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.